Anja Henn

1.3k total citations · 1 hit paper
10 papers, 1.0k citations indexed

About

Anja Henn is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Anja Henn has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Anja Henn's work include Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Anja Henn is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Anja Henn collaborates with scholars based in Germany, United States and Switzerland. Anja Henn's co-authors include Marcel Leist, Benno Rattel, Peter Kufer, Roman Kischel, Patrick A. Baeuerle, Tobias Raum, Joachim Wahl, Patrick Hoffmann, Kellen Schneider and Stefan W. Krause and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Leukemia.

In The Last Decade

Anja Henn

10 papers receiving 999 citations

Hit Papers

The suitability of BV2 cells as alternative model system ... 2009 2026 2014 2020 2009 200 400 600

Peers

Anja Henn
Shruti Nayak United States
Mathieu Marella United States
Judit Csejtey United States
Song Shi China
Christine Loh United States
Anja Henn
Citations per year, relative to Anja Henn Anja Henn (= 1×) peers Rebecca Conrad

Countries citing papers authored by Anja Henn

Since Specialization
Citations

This map shows the geographic impact of Anja Henn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Henn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Henn more than expected).

Fields of papers citing papers by Anja Henn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Henn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Henn. The network helps show where Anja Henn may publish in the future.

Co-authorship network of co-authors of Anja Henn

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Henn. A scholar is included among the top collaborators of Anja Henn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Henn. Anja Henn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Goldstein, Rebecca, Anja Henn, Petra Deegen, et al.. (2022). Abstract 6313: Evaluation of a dual CD123-FLT3 BiTE molecule for acute myeloid leukemia. Cancer Research. 82(12_Supplement). 6313–6313. 1 indexed citations
2.
Pham, Elizabeth, Anja Henn, Joachim Wahl, et al.. (2022). Abstract 5202: AMG 794, a Claudin 6-targeted half-life extended (HLE) bispecific T cell engager (BITE®) molecule for non-small cell lung cancer and epithelial ovarian cancer. Cancer Research. 82(12_Supplement). 5202–5202. 4 indexed citations
3.
Bailis, Julie M., Petra Lutterbuese, Oliver S. Thomas, et al.. (2020). Abstract 3364: Preclinical evaluation of BiTE®immune therapy targeting MUC17 or CLDN18.2 for gastric cancer. Cancer Research. 80(16_Supplement). 3364–3364. 8 indexed citations
4.
Arvedson, Tara, Mercedesz Balázs, Kurt A. Black, et al.. (2017). Abstract 55: Generation of half-life extended anti-CD33 BiTE® antibody constructs compatible with once-weekly dosing. Cancer Research. 77(13_Supplement). 55–55. 23 indexed citations
5.
Friedrich, Matthias, Anja Henn, Tobias Raum, et al.. (2014). Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia. Molecular Cancer Therapeutics. 13(6). 1549–1557. 106 indexed citations
6.
Aigner, Michael, Julian Feulner, Stefanie Schaffer, et al.. (2012). T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct. Leukemia. 27(5). 1107–1115. 101 indexed citations
7.
Henn, Anja, et al.. (2011). TLR2 Hypersensitivity of Astrocytes as Functional Consequence of Previous Inflammatory Episodes. The Journal of Immunology. 186(5). 3237–3247. 49 indexed citations
8.
Kremer, Marcel, Anja Henn, Cornelia Kolb, et al.. (2010). Reduced Immunoproteasome Formation and Accumulation of Immunoproteasomal Precursors in the Brains of Lymphocytic Choriomeningitis Virus-Infected Mice. The Journal of Immunology. 185(9). 5549–5560. 58 indexed citations
9.
Henn, Anja. (2009). The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX. 26(2). 83–94. 629 indexed citations breakdown →
10.
Henn, Anja, Diana P. N. Gonçalves, David Monchaud, et al.. (2008). Inhibition of Dicing of Guanosine‐Rich shRNAs by Quadruplex‐Binding Compounds. ChemBioChem. 9(16). 2722–2729. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026